AR and infection: Thus, having identified the overall most active AR compounds in our luminescence-based drug screen, we next used a flow cytometry-based methodology to independently assess these compound's ability to block the establishment of infection and/or to impair parasite development in the hepatic cells (Prudencio et al., 2008).